Glucocorticoid hypertension due to the use of bleaching skin cream, a case report

Acta Clinica Belgica

Volumn 60, Issue 3, 2005, Pages 146-149

  Bwomda, P ^a   Sermijn, E ^a   Lacor, P ^a   Velkeniers, Brigitte ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

11 hydroxysteroid deshydrogenase; Arterial hypertension; Cushing's syndrome; Glucocorticosteroids; Nitric oxide; Skin bleaching preparation; Vascular resistance

Indexed keywords

AMLODIPINE; BLEACHING AGENT; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; HYDROQUINONE; MERCURY DERIVATIVE; PREDNISOLONE; SPIRONOLACTONE; TETRACOSACTIDE;

ADULT; AMENORRHEA AND OLIGOMENORRHEA; ARTICLE; CASE REPORT; CREAM; CUSHING DISEASE; DERMATOLOGY; ESTHETICS; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY BLOOD FLOW; OSTEOPENIA; VASCULAR DISEASE; AMENORRHEA; CHEMICALLY INDUCED DISORDER; CUSHING SYNDROME; DRUG EFFECT; OINTMENT; SKIN PIGMENTATION;

ADULT; AMENORRHEA; CUSHING SYNDROME; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; OINTMENTS; SKIN PIGMENTATION;

EID: 26044473688     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2005.027     Document Type: Article

References (19)

1. Mahé A, Ly F, Aymard G and Dangou JM. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. British Journal of Dermatology. 2003: 493.
2. Perret JL, Sane M, Gning S, Ba K, Rohou G. Hypothalamo-hypophyseal- adrenal hypofunction caused by use of bleaching cosmetics in Senegal. Bull Soc Pathol Exot. 2001; 94(3): 249-252.
3. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996: 1206-1212.
4. Wester RC, Noonan PK and Haibach HI. Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo study in the rhesus monkey. Arch Dermatol. 1980; 116: 186-88.
5. Orth DN. Cushing's Syndrome. N Engl J Med. 1995: 332-791.
6. Ferrari P. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. Best Pract Res Clin Endocrinol Metab. 2003; 17(4): 575-589.
7. Dotsch J, Dorr HG, Stalla GK, Sippell WG. Effect of glucocorticoid excess on the cortisol/cortisone ratio. Steroids. 2001; 66(11): 817-20.
8. Torpy DJ, Mullen N, Ilias I, Nieman LK. Association of Hypertension and Hypokalemia with Cushing's Syndrome Caused by Ectopic ACTH secretion. Ann N Y Acad Sci. 2002; 970: 134-44.
9. Williamson PM, Kelly JJ, Whitworth JA. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J. Hypertens. 1996; suppl 14(5): S37-41.
10. Whitworth JA, Gordon D, Andrews, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens. 1989; 7(7): 537-49.
11. Brem AS, Bina RB, Fittpatrick C, King T, Tang SS, Ingelfinger JR. Glucocorticoid metabolism in proximal tubules modulates angiotensin II-induced electrolyte transport. Proc Soc Exp Biol Med. 1999; 221: 111-117.
12. Laplace JR, Husted RD, Slokes JB. Cellular responses to steroids in the enhancement of Na+ transport by rat collecting duct cells in culture. J Clin Invest. 1992; 90: 1370-78.
13. Sala C, Ambrosi B, Morganti A. Blunted vascular and renal effects of exogenous atrial natriuretic peptide in patients with Cushing's disease. J Clin Endocrinol Metab. 2001; 86(5): 1957-61.
14. Whitworth JA, Connell JM, Gordon D, Scoggins BA. Effects of indomethacin on steroid-induced changes in pressor responsiveness in man. Clin Exp Pharmacol Physiol. 1988; 15(4): 305-10.
15. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension. 1992; 19(6 Pt 1): 567-74.
16. Brem AS. Insights Into Glucocorticoid-Associated Hypertension. Am J Kidney. 2001; 37(1): 1-10.
17. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfahrt P, Kleinert H, Lehr HA, Lemmer B, Fostermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA. 1999; 96(23): 13357-62.
18. Whithworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ. The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens. 2002; 20(6): 1035-43.
19. Mitchell BM, Webb RC. Impaired vasodilation and nitric oxide synthase activity in glucocorticoid-induced hypertension. Biol Res Nurs. 2002; 4(1): 16-21.